Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases
- PMID: 7874573
- DOI: 10.3109/07357909509011689
Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases
Abstract
The occurrence of arterial thrombosis reported in other breast cancer series has largely been confined to the upper extremities, ipsilateral to a previous mastectomy site and clinically manifest as cerebral vascular accidents. This case report describes 2 patients who experienced iliac artery thrombosis temporally related to receiving granulocyte-macrophage colony-stimulating factor (GM-CSF) and dose-intensive chemotherapy for metastatic breast cancer. A review of the literature concerning arterial thrombosis as relevant to breast cancer treatment and GM-CSF is included.
Similar articles
-
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.Ann Oncol. 1994 Oct;5(8):709-16. doi: 10.1093/oxfordjournals.annonc.a058975. Ann Oncol. 1994. PMID: 7826903 Clinical Trial.
-
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy.Blood. 1995 Oct 15;86(8):2913-21. Blood. 1995. PMID: 7579383 Clinical Trial.
-
The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.Am J Clin Oncol. 1994 Oct;17(5):374-81; discussion 382. doi: 10.1097/00000421-199410000-00002. Am J Clin Oncol. 1994. PMID: 7522393 Clinical Trial.
-
The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone.Cancer Treat Rev. 1998 Jun;24(3):173-84. doi: 10.1016/s0305-7372(98)90048-2. Cancer Treat Rev. 1998. PMID: 9767733 Review. No abstract available.
-
Chemotherapy causes cancer! A case report of therapy related acute myeloid leukaemia in early stage breast cancer.Ulster Med J. 2013 May;82(2):97-9. Ulster Med J. 2013. PMID: 24082288 Free PMC article. Review.
Cited by
-
Acute myocardial infarction caused by filgrastim: a case report.Case Rep Oncol Med. 2012;2012:784128. doi: 10.1155/2012/784128. Epub 2012 Dec 23. Case Rep Oncol Med. 2012. PMID: 23326742 Free PMC article.
-
Hematological Malignancies and Arterial Thromboembolism.Indian J Hematol Blood Transfus. 2019 Oct;35(4):611-624. doi: 10.1007/s12288-019-01085-x. Epub 2019 Jan 28. Indian J Hematol Blood Transfus. 2019. PMID: 31741612 Free PMC article. Review.
-
Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.CNS Drugs. 2017 Nov;31(11):911-937. doi: 10.1007/s40263-017-0472-6. CNS Drugs. 2017. PMID: 29063471 Review.
-
Pathogenic mechanisms implicated in the intravascular coagulation in the lungs of BVDV-infected calves challenged with BHV-1.Vet Res. 2013 Mar 18;44(1):20. doi: 10.1186/1297-9716-44-20. Vet Res. 2013. PMID: 23506546 Free PMC article.
-
Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing.J Vasc Surg. 2007 Jun;45 Suppl A(Suppl A):A39-47. doi: 10.1016/j.jvs.2007.02.068. J Vasc Surg. 2007. PMID: 17544023 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical